Ganglioside embedded in reconstituted lipoprotein binds cholera toxin with elevated affinity.
The ability to exogenously present cell-surface receptors in high-affinity conformations in a synthetic system offers an opportunity to provide host cells with protection from pathogenic toxins. This strategy requires improvement of the synthetic receptor binding affinity against its native counterpart, particularly with polyvalent toxins where clustering of membrane receptors can hinder binding. Here we demonstrate that reconstituted lipoprotein, nanometer-sized discoidal lipid bilayers bounded by apolipoprotein and functionalized by incorporation of pathogen receptors, provides a means to enhance toxin-receptor binding through molecular-level control over the receptor microenvironment (specifically, its rigidity, composition, and heterogeneity). Using a Foerster Resonance Energy Transfer (FRET)-based assay, we found that reconstituted lipoprotein incorporating low concentrations of ganglioside monosialotetrahexosylganglioside (GM1) binds polymeric cholera toxin with significantly higher affinity than liposomes or supported lipid bilayers, most likely a result of the enhanced control over receptor clustering provided by the lipoprotein platform. Using wide-area epifluorescence, we found that this enhanced binding capacity can be effectively utilized to divert cholera toxin away from populations of healthy mammalian cells. In summary, we found that reconstitutions of high-density lipoprotein can be engineered to include specific pathogen receptors; that their pathogen binding affinity is altered, presumably due to attenuation of receptor aggregation; and that these assemblies are effective at protecting cells from biological toxins.
Bricarello
Daniel A
DA
Department of Applied Science, University of California, Davis, CA 95616, USA.
Mills
Emily J
EJ
Petrlova
Jitka
J
Voss
John C
JC
Parikh
Atul N
AN
D016632:Apolipoprotein A-I / Q000235:genetics / Q000378:metabolism; D002478:Cells, Cultured; D002772:Cholera Toxin / Q000378:metabolism*; D031541:Fluorescence Resonance Energy Transfer; D005732:Gangliosides / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D008051:Lipid Bilayers / Q000737:chemistry / Q000378:metabolism; D008074:Lipoproteins / Q000737:chemistry / Q000378:metabolism; D008081:Liposomes / Q000737:chemistry / Q000378:metabolism; D011485:Protein Binding; D055213:Retinal Pigment Epithelium / Q000166:cytology
C505693:APOA1 protein, human; D016632:Apolipoprotein A-I; D005732:Gangliosides; D008051:Lipid Bilayers; D008074:Lipoproteins; D008081:Liposomes; D002772:Cholera Toxin
J Am Chem Soc. 2008 May 21;130(20):6438-43
18412339
Mol Vis. 2006 Oct 27;12:1319-33
17110915
Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18534-9
17124175
Cell Mol Life Sci. 2000 Oct;57(11):1577-92
11092453
J Lipid Res. 1980 Nov;21(8):993-1003
6780646
Front Biosci. 2002 Mar 01;7:d717-25
11861224
J Biol Chem. 1977 Apr 10;252(7):2200-5
191456
J Am Chem Soc. 2007 May 9;129(18):5954-61
17429973
Anal Chem. 2008 Aug 15;80(16):6245-52
18616345
J Mammary Gland Biol Neoplasia. 1996 Jul;1(3):271-83
10887501
Semin Perinatol. 1999 Jun;23(3):242-9
10405194
J Clin Invest. 2001 Sep;108(6):785-91
11560944
Biochim Biophys Acta. 1978 Feb 21;507(2):280-93
203316
J Am Chem Soc. 2008 Aug 20;130(33):11164-9
18642906
J Biol Chem. 2000 Jun 9;275(23):17221-4
10770957
J Am Chem Soc. 2009 Jun 10;131(22):7508-9
19449869
Biochemistry. 2002 Feb 12;41(6):1742-51
11827518
J Biol Chem. 1977 Apr 10;252(7):2194-9
191455
Invest Ophthalmol Vis Sci. 2006 May;47(5):2172-8
16639029
Curr Opin Biotechnol. 2008 Dec;19(6):644-51
18977299
J Drug Target. 2008 Jul;16(6):502-8
18604663
Invest Ophthalmol Vis Sci. 1989 Feb;30(2):225-32
2536645
Protein Sci. 1994 Feb;3(2):166-75
8003954
Atheroscler Suppl. 2002 Dec;3(4):31-8
12573361
Glycoconj J. 2008 Oct;25(7):675-83
18498052
J Control Release. 2002 Apr 23;80(1-3):29-44
11943385
Nature. 2000 Aug 17;406(6797):782-7
10963608
Biochemistry. 1985 Jul 16;24(15):4097-108
3931673
Biochem Biophys Res Commun. 2002 Apr 12;292(4):1017-22
11944916
Biophys J. 2002 May;82(5):2526-35
11964241
Biophys J. 2004 Jun;86(6):3700-8
15189866
Protein Sci. 2003 Nov;12(11):2476-81
14573860
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15463-8
17030791
Protein Expr Purif. 2003 Jan;27(1):98-103
12509990
Nat Rev Drug Discov. 2003 May;2(5):347-60
12750738
J Biol Chem. 2007 May 18;282(20):14875-81
17395586
J Am Chem Soc. 2004 Nov 3;126(43):13962-72
15506757
Nat Struct Biol. 2003 Jun;10(6):455-60
12754494
J Struct Biol. 1998 Sep;123(1):37-44
9774543
Biochim Biophys Acta. 1985 Jul 25;817(2):229-37
4016104
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7682-7
17452637
Nature. 1997 Jun 5;387(6633):569-72
9177342
J Biol Chem. 1977 Jul 10;252(13):4701-11
194891
Adv Drug Deliv Rev. 2001 Apr 25;47(2-3):251-76
11311995